JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M413929200 on May 10, 2005

J. Biol. Chem., Vol. 280, Issue 26, 24931-24940, July 1, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/26/24931    most recent
M413929200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trakul, N.
Right arrow Articles by Rosner, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trakul, N.
Right arrow Articles by Rosner, M. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Raf Kinase Inhibitory Protein Regulates Raf-1 but Not B-Raf Kinase Activation*

Nicholas Trakul{ddagger}§, Raymond E. Menard§, George R. Schade§||, Zhijian Qian||, and Marsha Rich Rosner{ddagger}§**{ddagger}{ddagger}

From the {ddagger}Committee on Cancer Biology, the §Ben May Institute for Cancer Research, and the Departments of ||Medicine and **Neurobiology, Pharmacology, and Physiology, University of Chicago, Chicago, Illinois 60637

Raf kinase inhibitory protein (RKIP; also known as phosphatidylethanolamine-binding protein or PEBP) is a modulator of the Raf/MAPK signaling cascade and a suppressor of metastatic cancer. Here, we show that RKIP inhibits MAPK by regulating Raf-1 activation; specifically, RKIP acts subsequent to Raf-1 membrane recruitment, prevents association of Raf-1 and p21-activated kinase (PAK), and blocks phosphorylation of the Raf-1 kinase domain by PAK and Src family kinases. Mutation of the PAK and Src phosphorylation sites on Raf-1 to aspartate, a phosphate mimic, prevented RKIP association with or inhibition of Raf-1 signaling. Interestingly, although RKIP can interact with B-Raf, RKIP depletion had no effect on activation of B-Raf. Because c-Raf-1 and B-Raf are both required for maximal MAPK stimulation by epidermal growth factor in neuronal and epithelial cell lines, we determined whether RKIP significantly affects MAPK signaling. In fact, RKIP depletion increased not only the amplitude but also the sensitivity of MAPK and DNA synthesis to epidermal growth factor stimulation by up to an order of magnitude. These results indicate that selective modulation of c-Raf-1 but not B-Raf activation by RKIP can limit the dynamic range of the MAPK signaling response to growth factors and may play a critical role in growth and development.


Received for publication, December 10, 2004 , and in revised form, May 5, 2005.

* This work was supported by National Institutes of Health Training Grant 5 T32 CA09594 (to N. T.) and Grant NS33858 (to M. R. R.) and by a gift from the Cornelius Crane Trust Fund for Eczema Research (to M. R. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Both authors contributed equally to this work.

{ddagger}{ddagger} To whom correspondence should be addressed: Dept. of Neurobiology, Pharmacology, and Physiology, University of Chicago, 5841 S. Maryland Ave., MC6027, Chicago, IL 60637. Tel.: 773-702-0380; Fax: 773-702-4634; E-mail: m-rosner{at}uchicago.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
S. L. Fougner, J. Bollerslev, F. Latif, J. K. Hald, T. Lund, J. Ramm-Pettersen, and J. P. Berg
Low Levels of Raf Kinase Inhibitory Protein in Growth Hormone-Secreting Pituitary Adenomas Correlate with Poor Response to Octreotide Treatment
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1211 - 1216.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
F Al-Mulla, S Hagan, W Al-Ali, S P Jacob, A I Behbehani, M S Bitar, A Dallol, and W Kolch
Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability
J. Clin. Pathol., April 1, 2008; 61(4): 524 - 529.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
B. Wang, Y. Yang, and P. A. Friedman
Na/H Exchange Regulatory Factor 1, a Novel AKT-associating Protein, Regulates Extracellular Signal-regulated Kinase Signaling through a B-Raf-Mediated Pathway
Mol. Biol. Cell, April 1, 2008; 19(4): 1637 - 1645.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Vigneswara, J. D. Lowenson, C. D. Powell, M. Thakur, K. Bailey, S. Clarke, D. E. Ray, and W. G. Carter
Proteomic Identification of Novel Substrates of a Protein Isoaspartyl Methyltransferase Repair Enzyme
J. Biol. Chem., October 27, 2006; 281(43): 32619 - 32629.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.